Your browser doesn't support javascript.
loading
A stagewise response to mitochondrial dysfunction in mitochondrial DNA maintenance disorders.
Vincent, Amy E; Chen, Chun; Gomes, Tiago Bernardino; Di Leo, Valeria; Laalo, Tuomas; Pabis, Kamil; Capaldi, Rodrick; Marusich, Michael F; McDonald, David; Filby, Andrew; Fuller, Andrew; Lehmann Urban, Diana; Zierz, Stephan; Deschauer, Marcus; Turnbull, Doug; Reeve, Amy K; Lawless, Conor.
Afiliação
  • Vincent AE; Wellcome Centre for Mitochondrial Research, Clinical and Translational Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK; NIHR Biomedical Research Centre, Faculty of Medical Sciences, Newcastle University, Newcastle, UK; John Walton Muscular Dystrophy Research Cent
  • Chen C; Wellcome Centre for Mitochondrial Research, Bioscience Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
  • Gomes TB; Wellcome Centre for Mitochondrial Research, Clinical and Translational Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK; NIHR Biomedical Research Centre, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
  • Di Leo V; Wellcome Centre for Mitochondrial Research, Clinical and Translational Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
  • Laalo T; Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Pabis K; Wellcome Centre for Mitochondrial Research, Clinical and Translational Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
  • Capaldi R; Cellstate Biosciences, Tucson, AZ, United States.
  • Marusich MF; mAbDx, Inc., Eugene, OR, United States.
  • McDonald D; Innovation, Methodology and Application Research Theme, Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK; Flow Cytometry Core Facility, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
  • Filby A; Innovation, Methodology and Application Research Theme, Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK; Flow Cytometry Core Facility, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
  • Fuller A; Innovation, Methodology and Application Research Theme, Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK; Flow Cytometry Core Facility, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
  • Lehmann Urban D; Department of Neurology, Ulm University, Ulm, Germany.
  • Zierz S; Department of Neurology, Martin-Luther-University Halle-Wittenberg, Halle/Saale, Germany.
  • Deschauer M; Department of Neurology, Technical University Munich, Munich, Germany.
  • Turnbull D; Wellcome Centre for Mitochondrial Research, Clinical and Translational Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
  • Reeve AK; Wellcome Centre for Mitochondrial Research, Clinical and Translational Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
  • Lawless C; Wellcome Centre for Mitochondrial Research, Clinical and Translational Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK; NIHR Biomedical Research Centre, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
Biochim Biophys Acta Mol Basis Dis ; 1870(5): 167131, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38521420
ABSTRACT
Mitochondrial DNA (mtDNA) deletions which clonally expand in skeletal muscle of patients with mtDNA maintenance disorders, impair mitochondrial oxidative phosphorylation dysfunction. Previously we have shown that these mtDNA deletions arise and accumulate in perinuclear mitochondria causing localised mitochondrial dysfunction before spreading through the muscle fibre. We believe that mito-nuclear signalling is a key contributor in the accumulation and spread of mtDNA deletions, and that knowledge of how muscle fibres respond to mitochondrial dysfunction is key to our understanding of disease mechanisms. To understand the contribution of mito-nuclear signalling to the spread of mitochondrial dysfunction, we use imaging mass cytometry. We characterise the levels of mitochondrial Oxidative Phosphorylation proteins alongside a mitochondrial mass marker, in a cohort of patients with mtDNA maintenance disorders. Our expanded panel included protein markers of key signalling pathways, allowing us to investigate cellular responses to different combinations of oxidative phosphorylation dysfunction and ragged red fibres. We find combined Complex I and IV deficiency to be most common. Interestingly, in fibres deficient for one or more complexes, the remaining complexes are often upregulated beyond the increase of mitochondrial mass typically observed in ragged red fibres. We further find that oxidative phosphorylation deficient fibres exhibit an increase in the abundance of proteins involved in proteostasis, e.g. HSP60 and LONP1, and regulation of mitochondrial metabolism (including oxidative phosphorylation and proteolysis, e.g. PHB1). Our analysis suggests that the cellular response to mitochondrial dysfunction changes depending on the combination of deficient oxidative phosphorylation complexes in each fibre.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosforilação Oxidativa / DNA Mitocondrial / Doenças Mitocondriais / Proibitinas Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosforilação Oxidativa / DNA Mitocondrial / Doenças Mitocondriais / Proibitinas Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article